Dear customers, dear friends,

COVID-19 is a long-term companion by now – and still leaves us speechless at times – by its ability to change, to mutate, to show so much different behavior! Nevertheless, we are sure that we will add an important piece of control over the virus by our new assay: SARS-CoV-2 UTAB FS.

Introducing SARS-CoV-2 UTAB FS

DiaSys is particularly pleased to announce the launch of SARS-CoV-2 UTAB FS assay for quantification of SARS-CoV-2 total antibodies in human serum.

Success stories from Ghana and Algeria

Phyllyps Medical Diagnostics and Hospic Sarl are two of our strong partners in Africa. Read their latest success story with our products.

1 Year of Procalcitonin FS

One year ago and just before the global rise of the pandemic, DiaSys has launched the CE-marked reagent Procalcitonin FS for sepsis management.

Meet Alexandra Martins - Head of After Sales Support

Our Interview series: DiaSys colleagues speak up. From apprentice to professional, they talk about their way to DiaSys, their everyday work, give advice and share what makes them unique.